Growth Metrics

ADC Therapeutics (ADCT) Receivables - Other (2021 - 2022)

Historic Receivables - Other for ADC Therapeutics (ADCT) over the last 2 years, with Q4 2022 value amounting to $805000.0.

  • ADC Therapeutics' Receivables - Other rose 202.79% to $805000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $805000.0, marking a year-over-year increase of 202.79%. This contributed to the annual value of $805000.0 for FY2022, which is 202.79% up from last year.
  • ADC Therapeutics' Receivables - Other amounted to $805000.0 in Q4 2022, which was up 202.79% from $789000.0 recorded in Q4 2021.
  • Over the past 5 years, ADC Therapeutics' Receivables - Other peaked at $805000.0 during Q4 2022, and registered a low of $789000.0 during Q4 2021.